secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turning Point Brands, Inc. (TPB)
CIK:        0001290677
Form:       8-K
Filed at:   2021-10-12T23:59:59+00:00
Accession:  0001140361-21-034304
Event type: regulatory
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA rescinds Marketing Denial Order on TPB vapor products; products remain under review
--------------------------------------------------------------------------------

- On Oct 7, FDA rescinded its Sept 14 Marketing Denial Order for certain TPB vapor products, citing need for further review.
- All proprietary vapor products (incl. Solace e-liquids) will continue marketing while PMTAs remain under FDA review.
- TPB withdrew its petition for review and motion to stay filed with the 6th Circuit following the rescission.
- CEO Larry Wexler expressed encouragement and reiterated commitment to evidence-based PMTA process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1290677/000114036121034304/0001140361-21-034304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1290677/000114036121034304/brhc10029756_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-034304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer